open access

Vol 29, No 4 (2022)
Research Letter
Submitted: 2021-08-04
Accepted: 2022-04-28
Published online: 2022-05-30
Get Citation

Fulminant myocarditis and acute heart failure in the light of new American Heart Association 2020 guidelines. Mechanical cardiac support and endomyocardial biopsy. What should be first?

Joanna Płonka1, Ryszard Gawda2, Jerzy Sacha34, Jarosław Bugajski4, Tomasz Brzostowicz4, Maciej Molsa5, Tomasz Czarnik2, Karin Klingel6, Marek Gierlotka1
DOI: 10.5603/CJ.a2022.0052
·
Pubmed: 35762076
·
Cardiol J 2022;29(4):714-717.
Affiliations
  1. Department of Cardiology, University Hospital, Institute of Medical Sciences, University of Opole, Poland
  2. Department of Anesthesiology and Intensive Care and Regional ECMO Center, Institute of Medical Sciences, University of Opole, Poland
  3. Faculty of Physical Education and Physiotherapy, University of Technology, Opole, Poland
  4. Department of Cardiology, Opole University Hospital, Poland
  5. Department of Anesthesiology and Intensive Care and Regional ECMO Center, Opole University Hospital, Opole, Poland
  6. Cardiopathology, Institute for Pathology, University Hospital Tuebingen, Germany

open access

Vol 29, No 4 (2022)
Research letters — Clinical cardiology
Submitted: 2021-08-04
Accepted: 2022-04-28
Published online: 2022-05-30

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Fulminant myocarditis and acute heart failure in the light of new American Heart Association 2020 guidelines. Mechanical cardiac support and endomyocardial biopsy. What should be first?

Journal

Cardiology Journal

Issue

Vol 29, No 4 (2022)

Article type

Research Letter

Pages

714-717

Published online

2022-05-30

Page views

1726

Article views/downloads

291

DOI

10.5603/CJ.a2022.0052

Pubmed

35762076

Bibliographic record

Cardiol J 2022;29(4):714-717.

Authors

Joanna Płonka
Ryszard Gawda
Jerzy Sacha
Jarosław Bugajski
Tomasz Brzostowicz
Maciej Molsa
Tomasz Czarnik
Karin Klingel
Marek Gierlotka

References (8)
  1. Gawor M. Postępowanie w zapaleniu mięśnia sercowego o piorunującym przebiegu. Medycyna po Dyplomie. 2020; 10: 31–39.
  2. Rroku A, Kottwitz J, Heidecker B, et al. Update on myocarditis: what we know so far and where we may be heading. Eur Heart J Acute Cardiovasc Care. 2020 [Epub ahead of print]: 2048872620910109.
  3. Kociol RD, Cooper LT, Fang JC, et al. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation. 2020; 141(6): e69–e92.
  4. Tschöpe C, Van Linthout S, Klein O, et al. Mechanical unloading by fulminant myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA concepts. J Cardiovasc Transl Res. 2019; 12(2): 116–123.
  5. Gawda R, Marszalski M, Sacha J, et al. Concomitant use of veno-arterial extracorporeal membrane oxygenation and Impella in the intensive care unit: a case report of fulminant myocarditis with multi-organ failure. Anaesthesiol Intensive Ther. 2020; 52(1): 63–66.
  6. Maniuc O, Salinger T, Anders F, et al. Impella CP use in patients with non-ischaemic cardiogenic shock. ESC Heart Fail. 2019; 6(4): 863–866.
  7. van der Boon RMA, den Dekker WK, Meuwese CL, et al. Safety of endomyocardial biopsy in new-onset acute heart failure requiring veno-arterial extracorporeal membrane oxygenation. Circ Heart Fail. 2021; 14(8): e008387.
  8. Seferović PM, Tsutsui H, McNamara DM, et al. Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy. Eur J Heart Fail. 2021; 23(6): 854–871.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl